Vyne Therapeutics Inc.
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 45 institutions reported holding Vyne Therapeutics Inc. in their 13F filings, up 2 from Q4 2025. 5 opened new positions and 3 sold out. The largest holders were Nantahala Capital Management, LLC ($1.2M), Lynx1 Capital Management LP ($973K) and Shay Capital LLC ($962K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vyne Therapeutics Inc.
- CUSIP
- 92941V308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $1.5M |
| Exits | 3 | $47K |
All 13F filers, Q4 2025 → Q1 2026: 5,435,376 shares bought and 428,070 shares sold, net +5,007,306 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Nantahala Capital Management, LLC | 0.07% | Add +100.0% | 2,000,000 | $1.2M |
| Lynx1 Capital Management LP | 0.15% | New | 1,628,700 | $973K |
| Shay Capital LLC | 0.14% | Reduce -0.9% | 1,610,242 | $962K |
| Anson Funds Management LP | 0.10% | Reduce -2.5% | 1,243,106 | $743K |
| ADAR1 Capital Management, LLC | 0.04% | Add +319.2% | 1,063,899 | $636K |
| Deeter Investments LLP | 0.10% | No change | 1,000,000 | $598K |
| T3 Companies, LLC | 0.78% | No change | 945,000 | $565K |
| Braidwell LP | 0.02% | New | 916,077 | $547K |
| Citadel Advisors | 0.00% | Add +1585.3% | 514,443 | $307K |
| KVP Capital Advisors, LP | 0.22% | No change | 500,551 | $299K |
| Two Sigma Investments, LP | 0.00% | Add +93.8% | 426,412 | $255K |
| Acadian Asset Management LLC | 0.00% | Reduce -40.2% | 381,797 | $228K |
| Geode Capital Management, LLC | 0.00% | Add +43.3% | 322,711 | $193K |
| Ikarian Capital, LLC | 0.02% | No change | 264,912 | $158K |
| Vanguard Capital Management LLC | 0.00% | — | 264,557 | $158K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 183,443 | $110K |
| UBS Group AG | 0.00% | Add +186.5% | 179,784 | $108K |
| XTX Topco Ltd | 0.00% | Add +100.4% | 158,396 | $95K |
| Rangeley Capital, LLC | 0.08% | Add +18.1% | 118,064 | $71K |
| Jane Street Group, LLC | 0.00% | Add +32.2% | 95,645 | $57K |
| Boothbay Fund Management, LLC | 0.00% | No change | 81,371 | $49K |
| Susquehanna International Group, LLP | 0.00% | Reduce -42.4% | 57,784 | $35K |
| BlackRock, Inc. | 0.00% | No change | 44,405 | $27K |
| FNY Investment Advisers, LLC | 0.01% | Add +40.0% | 35,000 | $20K |
| HRT Financial LP | 0.00% | New | 27,569 | $16K |
| Northern Trust Corp. | 0.00% | No change | 23,110 | $14K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 18,298 | $11K |
| Renaissance Technologies | 0.00% | New | 17,300 | $10K |
| State Street Corp. | 0.00% | No change | 15,765 | $9K |
| Harvest Investment Services, LLC | 0.00% | No change | 11,059 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -1.1% | 3,527 | $2K |
| Acorn Capital Advisors, LLC | 0.00% | No change | 1,425 | $855 |
| Mb, Levis & Associates, LLC | 0.00% | No change | 1,041 | $622 |
| Vanguard Global Advisers, LLC | 0.00% | — | 1,004 | $600 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 800 | $478 |
| Hurley Capital, LLC | 0.00% | No change | 561 | $335 |
| Cwm, LLC | 0.00% | No change | 500 | $299 |
| JPMorgan Chase & Co. | 0.00% | No change | 146 | $86 |
| Wells Fargo & Company | 0.00% | No change | 65 | $39 |
| Morgan Stanley | 0.00% | No change | 43 | $26 |
| Truvestments Capital LLC | 0.00% | No change | 25 | $15 |
| NFSG Corp | 0.00% | No change | 10 | $6 |
| Larson Financial Group LLC | 0.00% | New | 2 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -99.4% | 15 | $0 |
| Centerpoint Advisors, LLC | 0.00% | No change | 350 | $0 |
"% of holder's portfolio" is VYNE THERAPEUTICS INC's weight in each manager's 13F, not the share of Vyne Therapeutics Inc. the manager owns.